 Connection
Jesse Schold to Severity of Illness Index
This is a "connection" page, showing publications Jesse Schold has written about Severity of Illness Index.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.897 |
|
|
|
-
Zubkov MR, Moore HB, Baimas-George M, Arrigain S, Lopez R, Brosi D, Brown K, Rodriguez IE, Nydam TL, Pomposelli JJ, Pomfret EA, Schold JD. Is Model for End-stage Liver Disease 3.0 Better Than Model for End-stage Liver Disease? Evaluating the Association of Liver Disease Severity Scores With Perioperative Complications in Liver Transplant Recipients. Transplant Proc. 2025 Oct; 57(8):1541-1548.
Score: 0.516
-
Jackson WE, Lopez R, Forman LM, Arrigain S, Schold JD. Marked variation in disease acuity and outcomes on the liver transplant waiting list by sociodemographic characteristics. Liver Transpl. 2025 May 01; 31(5):584-595.
Score: 0.121
-
Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
Score: 0.063
-
Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
Score: 0.046
-
Malamon JS, Kaplan B, Jackson WE, Saben JL, Schold JD, Pomfret EA, Pomposelli JJ. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study. Int J Surg. 2023 Sep 01; 109(9):2714-2720.
Score: 0.028
-
Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA. Survival Benefit of Living-Donor Liver Transplant. JAMA Surg. 2022 10 01; 157(10):926-932.
Score: 0.026
-
Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980.
Score: 0.020
-
Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
Score: 0.015
-
Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74.
Score: 0.015
-
Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
Score: 0.014
-
Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
Score: 0.012
-
Navaneethan SD, Schold JD, Srinivas TR. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010 Jan; 30(1):51-8.
Score: 0.011
-
Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May; 249(5):851-8.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|